supp.fit
All Coenzyme Q10 study protocols

Coenzyme Q10 and Selenium: study protocols

8 study groups took Coenzyme Q10 together with Selenium. These are the doses the studies gave. They are not a recommendation.

Coenzyme Q10: what the research found →

Dose per serving from research: Coenzyme Q10

8 study groups in 8 studies say how much Coenzyme Q10 participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 100 mg to 250 mg, 100% of 8 study groups.

Daily doseStudy groups
100 mg to 250 mg
8

Dose per serving from research: Selenium

8 study groups in 8 studies say how much Selenium participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 100 mcg to 250 mcg, 88% of 8 study groups.

Daily doseStudy groups
100 mcg to 250 mcg
7
250 mcg to 500 mcg
1

Commonly used together

None of these 8 study groups took Coenzyme Q10 and Selenium with anything else.

8 study groups

Study
Reduced Cardiovascular Mortality 10 Years after Supplementation with Selenium and Coenzyme Q10 for Four Years: Follow-Up Results of a Prospective Randomized Double-Blind Placebo-Controlled Trial in Elderly Citizens
2015 · Active treatment · Elderly Swedish community-dwelling adults; mean age 78 years; men and women; described as healthy, with low baseline selenium status
200 mg200 mcg4 years221
Still reduced cardiovascular mortality 12 years after supplementation with selenium and coenzyme Q10 for four years: A validation of previous 10-year follow-up results of a prospective randomized double-blind placebo-controlled trial in elderly
2018 · Active treatment group · Elderly healthy Swedish community-dwelling adults; mean age 78 years, men and women
200 mg200 mcg1461 days221
Supplementation with Selenium and Coenzyme Q10 Reduces Cardiovascular Mortality in Elderly with Low Selenium Status. A Secondary Analysis of a Randomised Clinical Trial
2016 · active treatment group · Adults aged 70–80 years in Sweden, without a stated requirement for a diagnosed condition; participants were analysed in strata by baseline serum selenium concentration.
200 mg200 mcg4 years219
Improved cardiovascular health by supplementation with selenium and coenzyme Q10: applying structural equation modelling (SEM) to clinical outcomes and biomarkers to explore underlying mechanisms in a prospective randomized double-blind placebo-controlled intervention project in Sweden
2022 · Active treatment group · Adults aged 70–88 years with low selenium status and age-related low coenzyme Q10 levels
200 mg400 mcg4 years221
Selenoprotein P increases upon selenium and coenzyme Q(10) supplementation and is associated with telomere length, quality of life and reduced inflammation and mortality
2024 · selenium yeast and coenzyme Q 10 supplementation · elderly community-living participants with low selenium status
200 mg200 mcg4 years—
Levels of sP-selectin and hs-CRP Decrease with Dietary Intervention with Selenium and Coenzyme Q10 Combined: A Secondary Analysis of a Randomized Clinical Trial
2015 · Active treatment · Adults aged 70–88 years from an elderly Swedish community population; no condition required for inclusion
200 mg200 mcg1461 days221
Effects of an Intervention with Selenium and Coenzyme Q(10) on Five Selected Age-Related Biomarkers in Elderly Swedes Low in Selenium: Results That Point to an Anti-Ageing Effect-A Sub-Analysis of a Previous Prospective Double-Blind Placebo-Controlled Randomised Clinical Trial
2023 · Active treatment · Elderly community-dwelling Swedes with low selenium status; age range not stated at intervention
200 mg200 mcg1461 days220
Selenium and coenzyme Q(10) improve the systemic redox status while reducing cardiovascular mortality in elderly population-based individuals
2023 · selenium and coenzyme Q10 supplementation · Elderly community-dwelling individuals with low levels of selenium and coenzyme Q10
200 mg200 mcg4 years—